Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London SM2 5NG, UK.
School of Pharmacy and Bioengineering, Keele University, Keele ST5 5BG, UK.
Molecules. 2022 Jan 26;27(3):817. doi: 10.3390/molecules27030817.
Heat Shock Protein 70s (HSP70s) are key molecular chaperones that are overexpressed in many cancers and often associated with metastasis and poor prognosis. It has proven difficult to develop ATP-competitive, drug-like small molecule inhibitors of HSP70s due to the flexible and hydrophilic nature of the HSP70 ATP-binding site and its high affinity for endogenous nucleotides. The aim of this study was to explore the potential for the inhibition of HSP70 through alternative binding sites using fragment-based approaches. A surface plasmon resonance (SPR) fragment screen designed to detect secondary binding sites in HSP70 led to the identification by X-ray crystallography of a cryptic binding site in the nucleotide-binding domain (NBD) of HSP70 adjacent to the ATP-binding site. Fragment binding was confirmed and characterized as ATP-competitive using SPR and ligand-observed NMR methods. Molecular dynamics simulations were applied to understand the interactions with the protein upon ligand binding, and local secondary structure changes consistent with interconversion between the observed crystal structures with and without the cryptic pocket were detected. A virtual high-throughput screen (vHTS) against the cryptic pocket was conducted, and five compounds with diverse chemical scaffolds were confirmed to bind to HSP70 with micromolar affinity by SPR. These results identified and characterized a new targetable site on HSP70. While targeting HSP70 remains challenging, the new site may provide opportunities to develop allosteric ATP-competitive inhibitors with differentiated physicochemical properties from current series.
热休克蛋白 70 家族(HSP70s)是关键的分子伴侣,在许多癌症中过度表达,通常与转移和预后不良有关。由于 HSP70 ATP 结合位点的柔性和亲水性以及其与内源性核苷酸的高亲和力,因此很难开发出具有 ATP 竞争性的、类似药物的 HSP70 小分子抑制剂。本研究旨在通过基于片段的方法探索通过替代结合位点抑制 HSP70 的潜力。设计用于检测 HSP70 中二级结合位点的表面等离子体共振(SPR)片段筛选导致通过 X 射线晶体学鉴定 HSP70 的核苷酸结合域(NBD)中紧邻 ATP 结合位点的隐蔽结合位点。使用 SPR 和配体观察 NMR 方法证实并表征了片段结合是 ATP 竞争性的。应用分子动力学模拟来了解配体结合时与蛋白质的相互作用,并检测到与观察到的晶体结构之间的相互转换一致的局部二级结构变化,这些晶体结构具有或不具有隐蔽口袋。对隐蔽口袋进行了虚拟高通量筛选(vHTS),并通过 SPR 证实了五种具有不同化学结构骨架的化合物以微摩尔亲和力与 HSP70 结合。这些结果确定并表征了 HSP70 上的一个新的可靶向位点。虽然靶向 HSP70 仍然具有挑战性,但新的位点可能为开发具有与现有系列不同物理化学特性的别构 ATP 竞争性抑制剂提供机会。